June 7-11, 2014St. Louis, MO 

Advanced gene sequencing has found a single genetic mutation essential for a brain disorder that has been plaguing Turkish families for centuries.

Among the many requirements a hospital must meet to achieve and maintain the designation of Critical Access Hospital (CAH), the hospital must be fairly remote and furnish 24-hour emergency care services seven days a week, using either on-site or on-call staff.

This issue isn't about false positives, it is about subjecting patients to treatment after mammography finds a small lesion, but when in all actuality that spot on the scan poses no real threat to the patient. Some cancers are never progressive and do not require serious treatment when to do so would come with its own risks and potential complications.

ABT Molecular Imaging has successfully implemented the first BG-75 Biomarker Generator in Russia. The project was completed in cooperation with the Diagnostic and Treatment Center of the International Institute of Biological Systems (DTC IIBS), St. Petersburg, Russia, and its U.S. representative, Owen Kane Molecular Imaging, Inc. (Owen Kane). 

SBRI contract to explore potential of low-cost commercial 3D scanner in healthcare applicationsOxford, UK & Greenville, NC – April 9, 2014 – Fuel 3D Technologies Ltd., developer of 3D scanning solutions, today announced it has secured a £685,831 ($1.1 million) SBRI Healthcare development contract for the development of a 3D medical imaging system. SBRI Healthcare is an NHS England initiative, which aims to promote UK economic growth while addressing unmet health needs and enhancing the take up of known best practice. Fuel 3D Technologies will use the contract to develop its Eykona scanner technology for a range of therapy applications and adoption in the NHS and international healthcare markets.

Drug policy in the European Union could change in the not too distant future depending on a vote regarding a law proposed to discourage pharmaceutical companies from playing favorites when it comes to clinical trials.

Samsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, today announced its first premium ultrasound system – the Samsung UGEO WS80A – designed to redefine ultrasound for women’s health. Combining Samsung’s latest medical imaging innovations and 5D technology, the Samsung UGEO WS80A is among a number of innovative medical imaging products Samsung is showcasing at the American Institute of Ultrasound in Medicine’s (AIUM) Annual Convention at Caesars Palace, Octavius Ballroom, Booth #301.